Latest Views & News

Monday Easter egg: The Twenty Most Listened-to Bearcasts of 2022, so far

By Darren Atwater | Monday 18 April 2022


Listen to the 20 most listened-to Bearcasts since January 1st and you'll hear nearly seven hours of Tom's dulcet tones unwinding the unexplainable, embarrassing the shameless, and chiding the ridiculous (Music Magpie holders? Chill Brands RNS's?) Plus cats, gardening, and, if I heard these correctly, life as a single mother.


  1. A free to access podcast from Tom Winnifrith for shareholders in Omega Diagnostics

    I guess you are all feeling a bit shafted right now and are wondering who to blame and what to do next after today’s debacle. Contrary to what you might read on certain Bulletin Boards I do not celebrate the pain of most Omega Diagnostics (ODX) shareholders, just those who abused and insulted my 100% accurate warnings of the bailout placing and other matters. For those chumps, it is schadenfreude all round. So what should you, as an Omega shareholder, do now? I answer that question and them discuss the legality of my reporting and indeed the morality of the reporting plus I explain exactly who shareholders should be angry with on a number of matters and why. Enjoy.  My regular daily podcast, behind the paywall, will go live later today.

  2. Tom Winnifrith Bonus Bearcast - why I think Skinbiotherapeutics is a 10 bagger (or more) from here

    As you know I am reviewing my pension as discussed. As such I am chatting to various CEOs who I have backed and yesterday evening I had a long chat with Stuart Ashman of Skinbiotherapeutics (SBTX). He is not a bluffing promoter but, I believe, a sober and grounded chap. I came away from the call just incredibly excited. I explain why the share price is where it is but also why this could within a couple of years be a 10 bagger but it could equally be a 20 bagger. Certainly any free cash within my SIPP will, even at twice today’s price be going into this stock. And if I am right there is a clear implication for Optibiotix (OPTI) so I am not selling any shares in it either.  Footnote/correction. There are not 2 million psoriasis sufferers worldwide as per podcast but 120 million. I can’t say that weakens the case!

  3. Tom Winnifrith Bearcast - Accepting the resignation of Peter Brailey as there is a line in the sand

    I want to be 100% transparent with you so I explain why, as of 8 AM today, Peter is no longer a member of this parish after apologising for yesterday’s poor sound quality for which there was a good reason. I look at two shocking economic statistics and what they mean. I then cover: SkinBiotherapeutics (SBTX), Bluebird Merchant Ventures (BMV),  AEX Gold (AEXG), Novacyt (NCYT), Avacta (AVCT) and Cake Box (CBOX). 

  4. Tom Winnifrith Bearcast: Here is why Kefi is a risk reward buy after yesterday

    Ahead of West Ham vs Kidderminster and Wales vs Ireland I am obviously rushing to get things done. But this is a full length Bearcast covering Kefi (KEFI), Love Hemp (LIFE) and Powerhouse Energy (PHE)

  5. Tom Winnifrith Bearcast - if the FCA really cared about financial promotions Gollum would be doing porridge

    In today’s bearcast I start with Cathie Wood of Ark Invest and another sign ( hat tip FP) that she is Neil Woodford on steroids and will see a mega blow up in 2022. The onto the FCA’s plan to crack down on financial promotions. My arse it will. If it was serious on this matter Gollum Gill would be in the slammer already. Then some consolation for Gary Newman with some words on Advance Energy (AVN). I comment on URU Metals (URU) and the there is Best of the Best (BOTB). Surely there must be a Steward’s intp the £60 million share dump by directors nine months ago.  But are the shares now cheap?  

  6. Tom Winnifrith Bearcast: A night of shame for Mello Events, and Skinbiotherapeutics - I'm buying more

    I start with Mello Events, which last night exposed itself as a PR promoter, failing to allow any questions about the elephant in the room: musicMagpie (MMAG).  Then to Optibiotix (OPTI) and Skinbiotherapeutics (SBTX), after today’s news from the latter. I have spoken to both Steve O’Hara and Stuart Ashman. As Les points out in the comments section, the silver lining for you is the postponement of my retirement – but not for long. The market has over-reacted: long-term, these two companies will subsidise the goat farm, as I explain in detail.

  7. Tom Winnifrith Bearcast: Ok I sacked him! And my pension reviewed with a new purchase

    I asked you whether I should fire someone last week. This morning I was pushed too far and did it. And then… well all is revealed in the podcast. I then discuss my pension. The most valuable holding is currently in at nil! But I then go through everything else I hold and what I have bought today to help me onto an early retirement and why.

  8. TomWinnifrith Bearcast: My SIPP buys more Optibiotix, Bluebird vs Kefi, & much more

    This is a very long podcast, covering: Optibiotix (OPTI); Skinbiotherapeutics (SBTX); Kefi (KEFI); Bluebird (BMV); Ten Lifestyle (TENG); CakeBox (CBOX); Deepverge (DVRG); Petropavlovsk (POG); Eurasia (EUA); and Amur Minerals (AMC).

  9. Tom Winnifrith Bearcast: All about Optibiotix apart from a few comments on the most despicable MBE out there

    I do comment about Julie Meyer’s latest tweet. Suicide is no joking matter and this act alone should see her lose her MBE. But most of this podcast is about events today at Optibiotix (OPTI) whose core businessis not worth MINUS £12 million as Mr Market implies. Ahead of the 24th March FYB! A pedant points out that at 14 mins in I say Optibiotix shareholders will get a distribution of 36-38%of Skinbiotherapeutics – clearly  meant Probiotix. Apologies – long covid strikes again.

  10. Tom Winnifrith Bearcast: Sitting on the fence with Lucian Miers

    I start with Ukraine, Russia and all that macro shite and say afew things which challenge the Western narrative and which some of you may disagree with violently. I cover Ferrexpo (FXPO),Amur (AMC) and Eurasia (EUA) in this section. I mention Cineworld (CINE) and then discuss today’s news from Optibiotix (OPTI) and, en passant, Skinbiotherapeutics (SBTX) where I am buying more shares this afternoon. 

  11. Tom Winnifrith Bearcast: How to play Ukraine and what to believe about what is happening? A detailed rebuttal of my Shield critics and THE crypto short

    I start with some thoughts on Ukraine and Russia which some of you may disagree with. Perhaps what is happening there will be a handy excuse for Eurasia Mining (EUA) to ‘fess up to the lack of bid? Then onto how bitcoin and other cryptos are faring as a safe haven right now. And why that makes Argo Blockchain (ARB) such a monumental sell. It could utterly implode. I see that more than 25% of posts on the ADVFN Bulletn Board,a few hours ago,were on Shield Therapeutics (STX) with nearly all of them slating me for all the usual reasons. I do not play the man here even though my critics do seem to have the collective IQ of a Cheese sandwich, but the ball and answer each of the bull points made to rebut my bear thesis in turn.

  12. Tom Winnifrith Bearcast: Reasons to defund the BBC No 897 - Martha Kearney, BP and dividends

    I start with the economically illiterate state broadcaster and almost despair. Then it is onto Gareth M Edwards, Duncan Soukup, Anemoi (AMOI) and Alina (ALNA). Then it is onto ADVFN (AFN), Eurasia Mining (EUA), Jubilee Metals (JLP), Omega Diagnostics (ODX) and Ocado (OCDO) 

  13. Tom Winnifrith Bearcast: Optibiotix & chatting to Steve O'Hara as Lemming Investor walks away

    In today’s podcast I discuss Optibiotix (OPTI), a long chat with Steve O’Hara and an, in my view, mistaken, but for him massive, call by Lemming Investor. I also cover SkinBiotherapeutics (SBTX).

  14. Tom Winnifrith Bonus Bearcast - 10 stocks to go to zero by Christmas

    Five others are mentioned but are not on the list. I explain why each will go to zero, and when. Not all of the 15 are shortable but a good many are. Enjoy.

  15. Tom Winnifrith Bearcast: So, what did I think of the Kefi presentation? Two passports? Here they both are...

    I start with news of flooding at the Welsh Hovel, and end with a reminder of podcasting schedules as I head to the Greek hovel. Then, I apologise to Peter Brailey as I cover: Simec Atlantic (SAE); Kefi (KEFI); Ince (INCE); Arden (ARDN); Cellular Goods (CBX); Chill Brands (FRAUD); Gatemore fund managers and Sensyne (SENS); Mark Slater and the folly of attempting corporate regime change; and Audioboom (BOOM).

  16. Tom Winnifrith Bearcast - Cake Box is NOT another Patisserie Holdings but it looks a stonking red flag & macro short

    I start with a few words on Oxford Cannabinoid (OCTP). I have not said fill your boots nor should you. The issue here is management allegedly lining their own pockets ahead of corporate action which they know all about. One should not buy shares in such companies. Then I reflect on an excellent piece by Maynard Paton on Cake Box (CBOX). I comment on some of the excellent points he makes but add in half a dozen of my own, notably comparing boasted net cash and net interest costs but also the shameful CEO pump and dump and the macro headwind given the demographic of its end user base. This is probably not another Patisserie Valerie but at 320p it is a stonking short.

  17. Tom Winnifrith Bearcast: The rank Nigel Farage hypocrisy, Hitchens, Syed, Nimmo and the great Chris Bailey

    I take a tour through four weekend press articles starting with that greedy scumbag Nigel Farage. Then to two great pieces on Ukraine and on the decadent West by Peter Hitchens and Matthew Syed respectvely before discussing the Sunday Times article on CBD and pot stocks. Finally I discuss Chris Bailey’s excellent piece on this website and my own approach to shares I own, mentioning Skinbiotherapeutics (SBTX) and some news breaking in the USA.

  18. Tom Winnifrith Bearcast: A sleazy PWC report does not excuse grotesque NED share option greed at Optibiotix, it stinks

    I start with a few minutes on Woodlarks. This may be my last year doing the Rogue Bloggers Walk but myself, Lucian Miers, and Jonathan Price are minded to do it once more in May or June. On the basis that it could be a last hurrah and that you may want to consider a way of shifting that Christmas belly bulge how about you join us in 2022? Then onto Optibiotix (OPTI) where its NEDs have behaved in a most disgraceful way with free money share option troughing. As a loyal shareholder this is another kick in the gonads for me and I urge Steve O’Hara to sack three of the four of them and replace them with one new, less greedy, individual. Actually I’d go for all four booting out chairman Neil Davidson as well.

  19. Tom Winnifrith Bearcast: Telling a gardener to feck off for being a Good German and a long chat with Steve O'Hara

    Yes I was dealing with a covidiot. We just cannot go on like this. If folks want to be Good Germans they can be but I cannot be arsed with such poltroons.  Then I look at Cineworld (CINE) prompted by this news from Ealing. My only question is whether my target is 0p or 2p.  Then SpaceandPeople (SAL) and words on overdrafts. That also applies to Omega Diagnostics (ODX) which I cover. Then today’s warning from the Bank of England is discussed and its importance and grim implications. Finally my chat with Steve O’Hara, forecasts for Optibotix (OPTI) and where the shares will be in three years.  

  20. Tom Winnifrith Bearcast: Dissecting the accelerating share price collapse at the fraud Chill Brands as I report a crime against me to the Police

    Okay the crime is not as exciting as it sounds and was not, as far as I know, perpetrated by some Bulletin Board loon. After discussing that I look at Chill Brands (CHLL), Brave Bison (BBSN) and Skinbiotherapeutics (SBTX)
This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Tuesday »


Synectics – a recovery Buy?



Malcolm Stacey is Moving House

Monday »


Wood Group - a Buy (again)?



Video: Bubbles always implode